Výsledky vyhledávání - Karel Pavelká
- Zobrazuji výsledky 1 - 20 z 78
- Přejít na další stránku
-
1
-
2
Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Tr... Autor Jean‐Yves Reginster, Jean Dudler, Tomasz Blicharski, Karel Pavelká
Vydáno 2017Artigo -
3
-
4
-
5
-
6
Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloar... Autor Andrea Levitová, Hana Hulejová, Maja Špiritović, Karel Pavelká, Ladislav Šenolt, Markéta Hušáková
Vydáno 2016Artigo -
7
-
8
-
9
A Study to Evaluate the Safety, Tolerability, and Efficacy of Brodalumab in Subjects with Rheumatoid Arthritis and an Inadequate Response to Methotrexate Autor Karel Pavelká, Yun Chon, Richard Newmark, Shao‐Lee Lin, Scott Baumgartner, Ngozi Erondu
Vydáno 2015Artigo -
10
-
11
Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis Autor Lucie Andrés Cerezo, H. Mann, Ondřej Pecha, Lenka Pleštilová, Karel Pavelká, Jiří Vencovský, Ladislav Šenolt
Vydáno 2011Artigo -
12
Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis Autor Vladimı́r Vilı́m, Richard Vytášek, Marta Olejárová, S Macháček, J Gatterová, Bohumír Procházka, Virginia B. Kraus, Karel Pavelká
Vydáno 2001Artigo -
13
-
14
Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-... Autor Olivier Bruyère, Karel Pavelká, Lucio C. Rovati, J Gatterová, Giampaolo Giacovelli, Marta Olejárová, Rita Deroisy, J.-Y. Reginster
Vydáno 2007Artigo -
15
-
16
Measurement of structural progression in osteoarthritis of the hip: the Barcelona consensus group11Supported by an unrestricted grant from NEGMA-LERADS Laboratories. Autor Robin Altman, D A Bloch, Maxime Dougados, Marc C. Hochberg, Stefan Lohmander, Karel Pavelká, Tim D. Spector, E. Vignon
Vydáno 2004Revisão -
17
Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlle... Autor Xavier Chevalier, Jörg Jerosch, Philippe Goupille, Nynke van Dijk, Frank P. Luyten, D L Scott, F. Bailleul, Karel Pavelká
Vydáno 2009Artigo -
18
S100A4 is expressed at site of invasion in rheumatoid arthritis synovium and modulates production of matrix metalloproteinases Autor Ladislav Šenolt, Mariam Grigorian, Eugene Lukanidin, Beat R. Simmen, BA Michel, Karel Pavelká, R E Gay, Steffen Gay, Michel Neidhart
Vydáno 2006Artigo -
19
-
20
MicroRNA-125b: association with disease activity and the treatment response of patients with early rheumatoid arthritis Autor Veronika Hrušková, Romana Jandová, Lucia Vernerová, H. Mann, Ondřej Pecha, Klára Prajzlerová, Karel Pavelká, Jiří Vencovský, Mária Filková, Ladislav Šenolt
Vydáno 2016Artigo
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Rheumatoid arthritis
Pathology
Alternative medicine
Physical therapy
Osteoarthritis
Gastroenterology
Rheumatology
Disease
Arthritis
Surgery
Immunology
Adverse effect
Biology
Intensive care medicine
Randomized controlled trial
Rituximab
Adalimumab
Antirheumatic Agents
Gene
Law
Lymphoma
Mathematics
Placebo
Political science
Biochemistry
Delphi method
Inflammation
Pharmacology